Form 4/A for BHVN Biohaven Ltd.
Accepted 2025-03-05 00:00:00 ET · period of report 2024-04-22 · accession 0001935979-25-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2025-03-05 | 2024-04-22 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $41.00 | +73.2K | 73.2K | New | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-04-22 | P | A | 73,170 | $41.00 | 73,170 | I By 2013 Charitable Remainder Trust | — | — | (F2) This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on April 23, 2024 (the "Original Form 4"). The Original Form 4 inadvertently misstated that 73,170 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 73,170 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and no Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. (F1) Represents common shares acquired in an underwritten public offering. |